Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Multigene expression from a replicating adenovirus using native viral promoters.

Bauzon M, Castro D, Karr M, Hawkins LK, Hermiston TW.

Mol Ther. 2003 Apr;7(4):526-34.

PMID:
12727116
2.

Gene delivery from the E3 region of replicating human adenovirus: evaluation of the 6.7 K/gp19 K region.

Hawkins LK, Johnson L, Bauzon M, Nye JA, Castro D, Kitzes GA, Young MD, Holt JK, Trown P, Hermiston TW.

Gene Ther. 2001 Aug;8(15):1123-31.

3.
4.

Linked tumor-selective virus replication and transgene expression from E3-containing oncolytic adenoviruses.

Zhu M, Bristol JA, Xie Y, Mina M, Ji H, Forry-Schaudies S, Ennist DL.

J Virol. 2005 May;79(9):5455-65.

5.

Deletion of the E3-6.7K/gp19K region reduces the persistence of wild-type adenovirus in a permissive tumor model in Syrian hamsters.

Bortolanza S, Bunuales M, Alzuguren P, Lamas O, Aldabe R, Prieto J, Hernandez-Alcoceba R.

Cancer Gene Ther. 2009 Sep;16(9):703-12. doi: 10.1038/cgt.2009.12.

PMID:
19229289
6.
7.
9.

Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.

Liu TC, Wang Y, Hallden G, Brooks G, Francis J, Lemoine NR, Kirn D.

Gene Ther. 2005 Sep;12(17):1333-46.

PMID:
15920462
10.

Comparison of the E3 and L3 regions for arming oncolytic adenoviruses to achieve a high level of tumor-specific transgene expression.

Robinson M, Ge Y, Ko D, Yendluri S, Laflamme G, Hawkins L, Jooss K.

Cancer Gene Ther. 2008 Jan;15(1):9-17.

PMID:
17853920
11.

Development of a transposon-based approach for identifying novel transgene insertion sites within the replicating adenovirus.

Kretschmer PJ, Jin F, Chartier C, Hermiston TW.

Mol Ther. 2005 Jul;12(1):118-27.

PMID:
15963927
13.

Replication-dependent transgene expression from a conditionally replicating adenovirus via alternative splicing to a heterologous splice-acceptor site.

Carette JE, Graat HC, Schagen FH, Abou El Hassan MA, Gerritsen WR, van Beusechem VW.

J Gene Med. 2005 Aug;7(8):1053-62.

PMID:
15756711
14.

[Treatment of hepatocellular carcinoma with a novel gene-viral therapeutic system CNHK300-murine endostatin].

Li GC, Nie MM, Yang JM, Su CQ, Sun LC, Qian YZ, Sham J, Fang GE, Wu MC, Qian QJ.

Zhonghua Yi Xue Za Zhi. 2004 Jun 2;84(11):943-8. Chinese.

PMID:
15329284
15.

Construction and characterization of E1-minus replication-defective adenovirus vectors that express E3 proteins from the E1 region.

Toth K, Kuppuswamy M, Doronin K, Doronina O, Lichtenstein D, Tollefson A, Wold W.

Virology. 2002 Sep 15;301(1):99-108.

16.

Noninvasive visualization of adenovirus replication with a fluorescent reporter in the E3 region.

Ono HA, Le LP, Davydova JG, Gavrikova T, Yamamoto M.

Cancer Res. 2005 Nov 15;65(22):10154-8.

17.

Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression.

Kuppuswamy M, Spencer JF, Doronin K, Tollefson AE, Wold WS, Toth K.

Gene Ther. 2005 Nov;12(22):1608-17.

PMID:
16034456
19.

A telomerase-dependent conditionally replicating adenovirus for selective treatment of cancer.

Wirth T, Zender L, Schulte B, Mundt B, Plentz R, Rudolph KL, Manns M, Kubicka S, K├╝hnel F.

Cancer Res. 2003 Jun 15;63(12):3181-8.

20.

ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis.

Yun CO, Kim E, Koo T, Kim H, Lee YS, Kim JH.

Cancer Gene Ther. 2005 Jan;12(1):61-71.

PMID:
15375379
Items per page

Supplemental Content

Support Center